| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 04/29/2026 | ±2.2% | -2.7% | under-priced |
| 02/20/2026 | ±1.6% | +0.0% | over-priced |
| 10/29/2025 | ±2.0% | -1.7% | over-priced |
| 07/30/2025 | ±1.6% | +0.4% | over-priced |
| 04/30/2025 | ±2.2% | +0.2% | over-priced |
| 02/21/2025 | ±1.6% | +1.3% | over-priced |
| 10/31/2024 | ±1.6% | -0.9% | over-priced |
| 07/31/2024 | ±3.3% | +0.6% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $0.61 | $11.2B | $1.1B |
| Q4 FY2025 | — | $11.5B | $1.8B |
| Q3 FY2025 | $0.94 | $11.4B | $1.6B |
| Q2 FY2025 | $1.01 | $11.1B | $1.8B |
ABT (ABT) reports imminently, with the next report estimated for 10/26/2026. Across the last 8 reports, options priced an average ±2.0% earnings move while the stock actually moved 1.0% on average — the market has systematically over-priced ABT's earnings risk. Fundamentals into the print: EPS down 19.7% year-over-year, revenue up 7.8%. QuantLogix's live 5-factor engine currently reads ABT as a buy at 80/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →